Healthcare Global Enterprises Ltd vs Yatharth Hospital Trauma Care Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Healthcare Global Enterprises Ltd is ₹ 584.8 as of 30 Oct 15:30 . The P/E Ratio of Healthcare Global Enterprises Ltd changed from 69.7 on March 2022 to 570.3 on March 2026 . This represents a CAGR of 52.26% over 5 yearsThe P/E Ratio of Yatharth Hospital & Trauma Care Services Ltd changed from 31.3 on March 2024 to 33.9 on March 2026 . This represents a CAGR of 2.70% over 3 years The Market Cap of Healthcare Global Enterprises Ltd changed from ₹ 2394 crore on March 2021 to ₹ 7833 crore on March 2026 . This represents a CAGR of 21.84% over 6 yearsThe Market Cap of Yatharth Hospital & Trauma Care Services Ltd changed from ₹ 3582 crore on March 2024 to ₹ 5946 crore on March 2026 . This represents a CAGR of 18.40% over 3 years The revenue of Healthcare Global Enterprises Ltd for the Jun '26 is ₹ 708.16 crore as compare to the Mar '26 revenue of ₹ 665.92 crore. This represent the growth of 6.34% The revenue of Yatharth Hospital & Trauma Care Services Ltd for the Jun '26 is ₹ 397.01 crore as compare to the Mar '26 revenue of ₹ 348.67 crore. This represent the growth of 13.86% The ebitda of Healthcare Global Enterprises Ltd for the Jun '26 is ₹ 135.32 crore as compare to the Mar '26 ebitda of ₹ 106.76 crore. This represent the growth of 26.75% The ebitda of Yatharth Hospital & Trauma Care Services Ltd for the Jun '26 is ₹ 96.04 crore as compare to the Mar '26 ebitda of ₹ 87.02 crore. This represent the growth of 10.37% The net profit of Healthcare Global Enterprises Ltd changed from ₹ 13.63 crore to ₹ 16.46 crore over 9 quarters. This represents a CAGR of 8.75% The net profit of Yatharth Hospital & Trauma Care Services Ltd changed from ₹ 30.38 crore to ₹ 45.42 crore over 9 quarters. This represents a CAGR of 19.57% The Dividend Payout of Healthcare Global Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Yatharth Hospital & Trauma Care Services Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Healthcare Global Enterprises Ltd

Healthcare Global Enterprises Limited was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a Private Limited Company.
The name of the Company was changed to HealthCare Global Enterprises Private Limited on November 14, 2005.
Thereafter, it was converted into a Public Limited Company and the name of the Company was changed to Healthcare Global Enterprises Limited on July 5, 2006. Presently, the Company is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.
Under the 'HCG' brand, the Company operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed by the AERB.

About Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospital & Trauma Care Services Limited was formerly incorporated as a Private Limited Company in Delhi dated February 28, 2008.
On November 3, 2021, the status converted into a Public Company and name of the Company was changed to Yatharth Hospital & Trauma Care Services Limited' on November 18, 2021 issued by the RoC. Yatharth Hospitals and Trauma Care Services Limited is a network of super speciality hospitals across Delhi National Capital Region (NCR) and Madhya Pradesh, capitalising on the robust healthcare infrastructure in these regions to serve a wide patient base in need of tertiary care. The Company operate three super specialty hospitals in Delhi NCR, i.e., at Greater Noida, Uttar Pradesh.
The super speciality tertiary care hospital currently operates with 400 beds, including 112 critical care beds and 9 modular operation theatres, among other surgical facilities.

FAQs for the comparison of Healthcare Global Enterprises Ltd and Yatharth Hospital & Trauma Care Services Ltd

Which company has a larger market capitalization, Healthcare Global Enterprises Ltd or Yatharth Hospital & Trauma Care Services Ltd?

Market cap of Healthcare Global Enterprises Ltd is 8,731 Cr while Market cap of Yatharth Hospital & Trauma Care Services Ltd is 8,942 Cr

What are the key factors driving the stock performance of Healthcare Global Enterprises Ltd and Yatharth Hospital & Trauma Care Services Ltd?

The stock performance of Healthcare Global Enterprises Ltd and Yatharth Hospital & Trauma Care Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Healthcare Global Enterprises Ltd and Yatharth Hospital & Trauma Care Services Ltd?

As of November 1, 2026, the Healthcare Global Enterprises Ltd stock price is INR ₹584.8. On the other hand, Yatharth Hospital & Trauma Care Services Ltd stock price is INR ₹928.05.

How do dividend payouts of Healthcare Global Enterprises Ltd and Yatharth Hospital & Trauma Care Services Ltd compare?

To compare the dividend payouts of Healthcare Global Enterprises Ltd and Yatharth Hospital & Trauma Care Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.